Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study finds “important shortcomings” in official cancer drug information

Written by | 10 Apr 2023

Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published… read more.

Breast MRI effective at detecting cancer in dense breasts

Written by | 2 Feb 2023

Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a study published in Radiology, a journal… read more.

Machine learning-triggered reminders improve end-of-life care for patients with cancer

Written by | 14 Jan 2023

Electronic nudges delivered to health care clinicians based on a machine learning algorithm that predicts mortality risk quadrupled rates of conversations with patients about their end-of-life care preferences,… read more.

How did the early COVID-19 pandemic affect cancer survivors?

Written by | 24 Aug 2022

Recent research indicates that during the first year of the COVID-19 pandemic, the proportion of working-aged U.S. adults without health insurance did not change despite increases in unemployment,… read more.

People with early-stage Hodgkin lymphoma face a higher risk of dying from cardiovascular disease than from cancer

Written by | 27 Jul 2022

Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but therapies can increase patients’ risk of developing heart… read more.

Bariatric surgery cuts cancer risks significantly

Written by | 8 Jul 2022

Obese adults who lost weight through bariatric surgery have achieved a significantly reduced risk of cancer and cancer-related death compared with obese adults who did not have such… read more.

Dostarlimab effective in rectal cancer subset

Written by | 5 Jul 2022

PD-1 blockade with adjuvant dostarlimab in mismatch repair–deficient, locally advanced rectal cancer shows signs of high efficacy, researchers reported on June 5, 2022 in the NEJM/ New England… read more.

Researchers develop hybrid sensor that can help diagnose cancer

Written by | 3 Jul 2022

A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today,… read more.

Improved treatment emerges for mantle cell lymphoma

Written by | 25 Jun 2022

Addition of ibrutinib to standard chemotherapy for patients over 65 with previously untreated mantle cell lymphoma (MCL) has led to significantly improved progression-free survival, researchers reported on June… read more.

Study finds COVID-19 pandemic reduced breast, cervical, colorectal cancer screenings by millions

Written by | 10 Jun 2022

New findings led by researchers at the American Cancer Society (ACS) show the number of women in the United States who reported having a recent (in the past year) breast cancer… read more.

“Breakthrough” COVID infections more prevalent and more dangerous for cancer patients

Written by | 3 Jun 2022

Breakthrough COVID-19 infection is more prevalent among vaccinated cancer patients than in the general population, and the results are more dangerous, researchers reported on April 8, 2022 in… read more.

One-off treatment shown to prevent long term side effects of cancer radiotherapies

Written by | 24 May 2022

A new study has found that a simple, one-off treatment was able to prevent long term side effects of cancer radiotherapies. There are about 2 million cancer survivors… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.